跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,049 条关于
“GUB-UCN2”
全部
4,049
临床试验
3,532
药物
285
机构
17
资讯
215
29天前
Gubra Advances Obesity Pipeline as AbbVie and Boehringer Ingelheim Programs Reach Phase 2
8个月前
Gubra Expands Facilities by 70% to Support Growing Peptide Drug Pipeline and CRO Operations
去年
Hanmi Pharmaceutical to Present Phase 1 Results of Next-Generation Obesity Drugs at ADA 2025
7天前
UB Awarded $5 Million to Lead SUNY Brain Institute Hub for Age-Related Brain Disorders
去年
Nimbus Therapeutics' NDI-101150, an Oral HPK1 Inhibitor, Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Gut Microbiota Emerges as Key Therapeutic Target for Osteoporosis Through Novel Gut-Bone Axis
去年
Diabetes Medications Show Promise in Easing Gum Disease
去年
LXR Activation Promotes Intestinal Healing and Suppresses Colorectal Cancer Growth
8年前
Protection of the Human Gut Microbiome From Antibiotics
去年
ARBs' Antihypertensive Effects Linked to Gut Microbiota Modulation
第 1 页,共 22 页
上一页
下一页